account_balance
Investment manager · 13F filer · SEC CIK 1807489
M28 Capital Management LP
Reported value$36Mas of Sep 30, 2026
Positions9 0 new, 0 sold out
Top 10 weight100.0%WVE alone is 47%
FiledNov 1344 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 9 stocks.
WVEWave Life Sciences, Inc.
47.1%
IVVDInvivyd, Inc.
22.3%
TGTXTG Therapeutics, Inc.
13.7%
ARWRArrowhead Pharmaceuticals, Inc.
6.7%
SLNSilence Therapeutics PLC
3.1%
GUTSFractyl Health, Inc.
2.8%
PRQRProQR Therapeutics N.V.
2.8%
WVEWave Life Sciences, Inc.
47.1%
IVVDInvivyd, Inc.
22.3%
TGTXTG Therapeutics, Inc.
13.7%
ARWR6.7%SLN3.1%GUTSPRQR2.8%Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 9 as a list
WVE Wave Life Sciences, Inc. 47.1% HeldIVVD Invivyd, Inc. 22.3% HeldTGTX TG Therapeutics, Inc. 13.7% HeldARWR Arrowhead Pharmaceuticals, Inc. 6.7% HeldSLN Silence Therapeutics PLC 3.1% HeldGUTS Fractyl Health, Inc. 2.8% HeldPRQR ProQR Therapeutics N.V. 2.8% HeldRCKT Rocket Pharmaceuticals, Inc. 1.5% HeldCRIS Curis Inc 0.0% Trimmed −95%
What changed
Biggest moves since Jun 30, 2026
add_circleNew
None
arrow_upwardAdded
None
arrow_downwardTrimmed
None
remove_circleSold out
None
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.